-Advertisement-
-Advertisement-
Home
FDA approves Omvoh for Crohn’s disease, expanding treatment options for inflammatory bowel disease
Gastroenterology
FDA approves Omvoh for Crohn’s disease, expanding treatment options for inflammatory bowel disease
The U.S. Food and Drug Administration has approved Omvoh (mirikizumab-mrkz; Eli Lilly) for treating adults with moderately to severely active Crohn's disease, expanding its use to a second major type of inflammatory bowel disease, according to a press release. This approval is based on positive results from the Phase 3...
Read More-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement-
Contact
© 2025 Med Journal 360® is a trademark of International Healthcare Media, LLC. All rights Reserved